+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Addictions Therapeutics Market 2023-2027

  • PDF Icon

    Report

  • 120 Pages
  • October 2022
  • Region: Global
  • TechNavio
  • ID: 5237568
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the addictions therapeutics market and it is poised to grow by $9.86 billion during 2023-2027, accelerating at a CAGR of 7.65% during the forecast period. This report on the addictions therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

This report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness about and combat addiction.

The addictions therapeutics market analysis includes the distribution channel and type segments and geographic landscape.

The publisher's addictions therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Others

By Type

  • Alcohol addiction therapeutics
  • Tobacco addiction therapeutics
  • Drug addiction therapeutics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing R&D of novel drugs as one of the prime reasons driving the addictions therapeutics market growth during the next few years. Also, the emergence of free state-run addiction treatment programs and facilities and increasing alcohol consumption among women will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on the addictions therapeutics market covers the following areas:
  • Addictions therapeutics market sizing
  • Addictions therapeutics market forecast
  • Addictions therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics market vendors that include Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Aphios Corp., Braeburn Inc., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Indivior Plc, Johnson and Johnson, kaleo Inc., Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., and Viatris Inc. Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Five Forces Analysis
4.1 Five forces summary
  • Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
  • Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
  • Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
  • Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
  • Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
  • Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
4.7 Market condition
  • Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by Distribution Channel
5.1 Market segments
  • Exhibit 25: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 26: Data Table on Distribution Channel - Market share 2022-2027 (%)
5.2 Comparison by Distribution Channel
  • Exhibit 27: Chart on Comparison by Distribution Channel
  • Exhibit 28: Data Table on Comparison by Distribution Channel
5.3 Hospital pharmacy - Market size and forecast 2022-2027
  • Exhibit 29: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 30: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 31: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
  • Exhibit 32: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
5.4 Retail pharmacy - Market size and forecast 2022-2027
  • Exhibit 33: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 34: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
  • Exhibit 36: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
5.5 Others - Market size and forecast 2022-2027
  • Exhibit 37: Chart on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 38: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 40: Data Table on Others - Year-over-year growth 2022-2027 (%)
5.6 Market opportunity by Distribution Channel
  • Exhibit 41: Market opportunity by Distribution Channel ($ billion)
6 Market Segmentation by Type
6.1 Market segments
  • Exhibit 42: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 43: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
  • Exhibit 44: Chart on Comparison by Type
  • Exhibit 45: Data Table on Comparison by Type
6.3 Alcohol addiction therapeutics - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 47: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 48: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.4 Tobacco addiction therapeutics - Market size and forecast 2022-2027
  • Exhibit 50: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 51: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 52: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibit 53: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.5 Drug addiction therapeutics - Market size and forecast 2022-2027
  • Exhibit 54: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 55: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 56: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibit 57: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
  • Exhibit 58: Market opportunity by Type ($ billion)
7 Customer Landscape
7.1 Customer landscape overview
  • Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Exhibit 60: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 61: Data Table on Market share By Geographical Landscape 2022-2027 (%)
8.2 Geographic comparison
  • Exhibit 62: Chart on Geographic comparison
  • Exhibit 63: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2022-2027
  • Exhibit 64: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 65: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 66: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 67: Data Table on North America - Year-over-year growth 2022-2027 (%)
8.4 Europe - Market size and forecast 2022-2027
  • Exhibit 68: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 69: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 70: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 71: Data Table on Europe - Year-over-year growth 2022-2027 (%)
8.5 Asia - Market size and forecast 2022-2027
  • Exhibit 72: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 73: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 74: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 75: Data Table on Asia - Year-over-year growth 2022-2027 (%)
8.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
8.7 US - Market size and forecast 2022-2027
  • Exhibit 80: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 81: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 82: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 83: Data Table on US - Year-over-year growth 2022-2027 (%)
8.8 Germany - Market size and forecast 2022-2027
  • Exhibit 84: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 85: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 86: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 87: Data Table on Germany - Year-over-year growth 2022-2027 (%)
8.9 Canada - Market size and forecast 2022-2027
  • Exhibit 88: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 89: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 90: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 91: Data Table on Canada - Year-over-year growth 2022-2027 (%)
8.10 UK - Market size and forecast 2022-2027
  • Exhibit 92: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 93: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 94: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 95: Data Table on UK - Year-over-year growth 2022-2027 (%)
8.11 France - Market size and forecast 2022-2027
  • Exhibit 96: Chart on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 97: Data Table on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 98: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 99: Data Table on France - Year-over-year growth 2022-2027 (%)
8.12 Market opportunity By Geographical Landscape
  • Exhibit 100: Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
10.4 Industry risks
  • Exhibit 104: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
  • Exhibit 105: Vendors covered
11.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
11.3 Alkermes Public Ltd. Co.
  • Exhibit 107: Alkermes Public Ltd. Co. - Overview
  • Exhibit 108: Alkermes Public Ltd. Co. - Product/Service
  • Exhibit 109: Alkermes Public Ltd. Co. - Key news
  • Exhibit 110: Alkermes Public Ltd. Co. - Key offerings
11.4 Amneal Pharmaceuticals Inc.
  • Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
  • Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
  • Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
  • Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
  • Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
11.5 Aphios Corp.
  • Exhibit 116: Aphios Corp. - Overview
  • Exhibit 117: Aphios Corp. - Product/Service
  • Exhibit 118: Aphios Corp. - Key offerings
11.6 Braeburn Inc.
  • Exhibit 119: Braeburn Inc. - Overview
  • Exhibit 120: Braeburn Inc. - Product/Service
  • Exhibit 121: Braeburn Inc. - Key offerings
11.7 Emergent BioSolutions Inc.
  • Exhibit 122: Emergent BioSolutions Inc. - Overview
  • Exhibit 123: Emergent BioSolutions Inc. - Product/Service
  • Exhibit 124: Emergent BioSolutions Inc. - Key news
  • Exhibit 125: Emergent BioSolutions Inc. - Key offerings
11.8 GlaxoSmithKline Plc
  • Exhibit 126: GlaxoSmithKline Plc - Overview
  • Exhibit 127: GlaxoSmithKline Plc - Business segments
  • Exhibit 128: GlaxoSmithKline Plc - Key offerings
  • Exhibit 129: GlaxoSmithKline Plc - Segment focus
11.9 Glenmark Pharmaceuticals Ltd.
  • Exhibit 130: Glenmark Pharmaceuticals Ltd. - Overview
  • Exhibit 131: Glenmark Pharmaceuticals Ltd. - Product/Service
  • Exhibit 132: Glenmark Pharmaceuticals Ltd. - Key offerings
11.10 Hikma Pharmaceuticals Plc
  • Exhibit 133: Hikma Pharmaceuticals Plc - Overview
  • Exhibit 134: Hikma Pharmaceuticals Plc - Business segments
  • Exhibit 135: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibit 136: Hikma Pharmaceuticals Plc - Segment focus
11.11 Indivior Plc
  • Exhibit 137: Indivior Plc - Overview
  • Exhibit 138: Indivior Plc - Product/Service
  • Exhibit 139: Indivior Plc - Key offerings
11.12 Mallinckrodt Plc
  • Exhibit 140: Mallinckrodt Plc - Overview
  • Exhibit 141: Mallinckrodt Plc - Business segments
  • Exhibit 142: Mallinckrodt Plc - Key news
  • Exhibit 143: Mallinckrodt Plc - Key offerings
  • Exhibit 144: Mallinckrodt Plc - Segment focus
11.13 Orexo AB
  • Exhibit 145: Orexo AB - Overview
  • Exhibit 146: Orexo AB - Product/Service
  • Exhibit 147: Orexo AB - Key offerings
11.14 Otsuka Holdings Co. Ltd.
  • Exhibit 148: Otsuka Holdings Co. Ltd. - Overview
  • Exhibit 149: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibit 150: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibit 151: Otsuka Holdings Co. Ltd. - Segment focus
11.15 Pfizer Inc.
  • Exhibit 152: Pfizer Inc. - Overview
  • Exhibit 153: Pfizer Inc. - Product/Service
  • Exhibit 154: Pfizer Inc. - Key news
  • Exhibit 155: Pfizer Inc. - Key offerings
11.16 Teva Pharmaceutical Industries Ltd.
  • Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
11.17 Titan Pharmaceuticals Inc.
  • Exhibit 161: Titan Pharmaceuticals Inc. - Overview
  • Exhibit 162: Titan Pharmaceuticals Inc. - Product/Service
  • Exhibit 163: Titan Pharmaceuticals Inc. - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Exhibit 164: Inclusions checklist
  • Exhibit 165: Exclusions checklist
12.3 Currency conversion rates for US$
  • Exhibit 166: Currency conversion rates for US$
12.4 Research methodology
  • Exhibit 167: Research methodology
  • Exhibit 168: Validation techniques employed for market sizing
  • Exhibit 169: Information sources
12.5 List of abbreviations
  • Exhibit 170: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)
Exhibits:
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on Global addictions therapeutics market 2017 - 2021 ($ billion)
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibit 22: Five forces analysis - Comparison between2022 and 2027
Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 25: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 28: Chart on Market condition - Five forces 2022 and 2027
Exhibit 29: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 30: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Chart on Comparison by Distribution Channel
Exhibit 32: Data Table on Comparison by Distribution Channel
Exhibit 33: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 34: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 38: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 40: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 42: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 44: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Market opportunity by Distribution Channel ($ billion)
Exhibit 46: Chart on Type - Market share 2022-2027 (%)
Exhibit 47: Data Table on Type - Market share 2022-2027 (%)
Exhibit 48: Chart on Comparison by Type
Exhibit 49: Data Table on Comparison by Type
Exhibit 50: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 54: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 55: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 57: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 58: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 59: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 61: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 62: Market opportunity by Type ($ billion)
Exhibit 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 64: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 65: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Chart on Geographic comparison
Exhibit 67: Data Table on Geographic comparison
Exhibit 68: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 83: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 87: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 91: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 95: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 99: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 103: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibit 104: Market opportunity By Geographical Landscape ($ billion)
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
Exhibit 107: Overview on factors of disruption
Exhibit 108: Impact of key risks on business
Exhibit 109: Vendors covered
Exhibit 110: Matrix on vendor position and classification
Exhibit 111: Alkermes Public Ltd. Co. - Overview
Exhibit 112: Alkermes Public Ltd. Co. - Product/Service
Exhibit 113: Alkermes Public Ltd. Co. - Key news
Exhibit 114: Alkermes Public Ltd. Co. - Key offerings
Exhibit 115: Amneal Pharmaceuticals Inc. - Overview
Exhibit 116: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 117: Amneal Pharmaceuticals Inc. - Key news
Exhibit 118: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 119: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 120: Aphios Corp. - Overview
Exhibit 121: Aphios Corp. - Product/Service
Exhibit 122: Aphios Corp. - Key offerings
Exhibit 123: Braeburn Inc. - Overview
Exhibit 124: Braeburn Inc. - Product/Service
Exhibit 125: Braeburn Inc. - Key offerings
Exhibit 126: Emergent BioSolutions Inc. - Overview
Exhibit 127: Emergent BioSolutions Inc. - Product/Service
Exhibit 128: Emergent BioSolutions Inc. - Key news
Exhibit 129: Emergent BioSolutions Inc. - Key offerings
Exhibit 130: GlaxoSmithKline Plc - Overview
Exhibit 131: GlaxoSmithKline Plc - Business segments
Exhibit 132: GlaxoSmithKline Plc - Key offerings
Exhibit 133: GlaxoSmithKline Plc - Segment focus
Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 137: Hikma Pharmaceuticals Plc - Overview
Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 141: Indivior Plc - Overview
Exhibit 142: Indivior Plc - Product/Service
Exhibit 143: Indivior Plc - Key offerings
Exhibit 144: Mallinckrodt Plc - Overview
Exhibit 145: Mallinckrodt Plc - Business segments
Exhibit 146: Mallinckrodt Plc - Key news
Exhibit 147: Mallinckrodt Plc - Key offerings
Exhibit 148: Mallinckrodt Plc - Segment focus
Exhibit 149: Orexo AB - Overview
Exhibit 150: Orexo AB - Product/Service
Exhibit 151: Orexo AB - Key offerings
Exhibit 152: Otsuka Holdings Co. Ltd. - Overview
Exhibit 153: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 154: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 155: Otsuka Holdings Co. Ltd. - Segment focus
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product/Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 165: Titan Pharmaceuticals Inc. - Overview
Exhibit 166: Titan Pharmaceuticals Inc. - Product/Service
Exhibit 167: Titan Pharmaceuticals Inc. - Key offerings
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
Exhibit 170: Currency conversion rates for US$
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
Exhibit 174: List of abbreviations

Executive Summary

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes the publisher's platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Alkermes Public Ltd. Co.
  • Amneal Pharmaceuticals Inc.
  • Aphios Corp.
  • Braeburn Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals Plc
  • Indivior Plc
  • Johnson and Johnson
  • kaleo Inc.
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Purdue Pharma LP
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Titan Pharmaceuticals Inc.
  • Viatris Inc.